Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Sanofi
 More »

  • Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology
    in clinical phases through collaborations with Amgen, Bayer HealthCare, Biotest, and Sanofi. The deal, which could generate up to $200M, is the second by the companies under a ...
    10-11-2013
  • Takeover Targets: Who Is First on the List?
    ... Also last year, Regeneron joined Sanofi in obtaining FDA approval for Zaltrap® ... of their relationship with Sanofi and the financial structure of their collaboration." ...
    9-24-2013
  • Sanofi Opens Cancer Research Hub in Cambridge, MA
    Sanofi opened a new research and development facility in Cambridge, MA, where 250 ... combined greater Boston workforce of Sanofi and its Genzyme biotech subsidiary, which ...
    9-20-2013
  • Genzyme's MS Drug Lemtrada Receives EU Authorization
    The Sanofi subsidiary said it will "soon" launch both Lemtrada and Aubagio® ... remitting multiplE scleRosis) trials. Sanofi unit wins first global regulatory OK for ...
    9-17-2013
  • Sanofi to Commercialize Pozen Proton Pump Inhibitor/Aspirin Product
    Sanofi signed an exclusive license agreement with Pozen to commercialize Pozen's ... Sanofi will have exclusive rights to commercialize all PA combinations that contain 325 mg ...
    9-5-2013
  • Mining Microbes for Promising Therapies
    Warp Drive was launched in 2012 through a partnership with Sanofi and with funding from ... He loved it so much he began using the term 'warp speed' at Sanofi," Dr. Verdine ...
    9-1-2013
  • Top Biotech & Pharma Companies
    have outpaced Big Pharma (e.g., Johnson & Johnson, Pfizer, Roche, Novartis, and Sanofi) in terms of growth of sales, income, and investment in R&D during the past three years. ...
    9-1-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    ... ProPublica has tallied more than $2 billion from 15 biopharmas since 2009. Until the Sunshine Act, some drug giants including Amgen, Bayer, Sanofi, and Roche disclosed no payment ...
    8-29-2013
  • Getting Ready for the Flu
    ... Infectious Diseases before becoming chief science officer at Sanofi in December 2012.) Dr. ... Dr. Nabel and his team at Sanofi in Cambridge developed vaccine nanoparticles using ...
    8-13-2013
  • Vical Scraps Melanoma Candidate After Phase III Failure
    ... Two of Vical's products have been licensed for animal indications by other companies: In 2009 before its acquisition by Sanofi, Merial won approval from the U.S. Department of ...
    8-12-2013
  • Double Manufacturing Deals for Sanofi
    Two Sanofi companies have entered biomanufacturing deals with Vivus and Gallus Biopharmaceuticals. Sanofi subsidiary Sanofi Chimie has made an agreement with Vivus to manufacture ...
    8-1-2013
  • High School Whiz Kids Win Scientific Prestige . . . and Big Bucks
    ... a Sanofi BioGENEius Challenge Canada prize for his cancer research. Arjun Nair, 16, who is an 11th grader at Webber Academy in Calgary, Alberta, Canada, took home the top Sanofi ...
    8-1-2013
  • What the Top 15 Biopharma CEOs Are Making
    As a result, this year the CEOs from Roche and Sanofi joined Novartis in raising the ... #15. Christopher Viehbacher Company: Sanofi Full title: CEO 2012 Compensation: ...
    7-31-2013
  • EFPIA, PhRMA: Trial Data-Sharing Benefits Patients, Scientists...
    being put forth in the European Union." Added EFPIA President and member company Sanofi CEO Christopher Viehbacher: "By endorsing the Principles, biopharmaceutical companies ...
    7-25-2013
  • Top 15 Pharma Companies of 2013
    pharmas climbed up the list (Novartis and Sanofi); four slipped a notch or more (Roche, ... 19.6% Position on 2012 List: #4 #5. Sanofi 2013 Market Cap: $148.381 billion (5/10: ...
    7-19-2013
  • More »

    Journal Articles

  • Validation of the SoloSTAR Insulin Pen
    Sherwyn Schwartz, Aleksandra Vlajnic
    Diabetes Technology & Therapeutics
    Diabetes Technology & Therapeutics Abstract Background: This study was designed to validate the use of SoloSTAR® (sanofi-aventis Deutschland GmbH, Frankfurt, Germany), a new ...
  • Dose Accuracy of SoloSTAR and FlexPen as Assessed in a Clinical...
    Arnd Friedrichs
    Diabetes Technology & Therapeutics
    Diabetes Technology & Therapeutics Abstract Aims: This study aimed to compare the accuracy of SoloSTAR® (sanofi-aventis, Paris, France) and FlexPen® (Novo Nordisk, Bagsvaerd, ...
  • Performance of a New Reusable Insulin Pen
    Alfred Penfornis
    Diabetes Technology & Therapeutics
    ease of use and performance of the ClikSTAR® (sanofi-aventis, Paris, France) insulin pen with other commonly used reusable pens based on participant and interviewer assessments. ...
  • The Best Insulin Injection Pen Device for Caregivers: Results...
    Fumiatsu Yakushiji, Hiroshi Fujita, Yoshiyasu Terayama, Mutsuko Yasuda, Kaoru Nagasawa, Masako Shimojo, Ken Taniguchi, Kazuhiko Fujiki, Jyunji Tomiyama, Hiroyuki Kinoshita
    Diabetes Technology & Therapeutics
    Methods: We evaluated five devices-OptiClik® (Sanofi-aventis, Paris, France), SoloStar® (Sanofi-aventis), MirioPen® without an antiskid tool (Eli Lilly and Co., Indianapolis, ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll